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1. Introduction
Cerebral amyloid angiopathy (CAA) is an important but under-recognized cause of sponta‐
neous intracranial hemorrhage (ICH) in the normotensive individuals. [1] Both sporadic and
hereditary forms may occur. Hereditary form of CAA is seen at a younger age, as early as the
third decade; in contrast, the sporadic form is more common in elderly and increases in both
prevalence and severity with increasing age. CAA results from deposition of β-amyloid protein
in small and medium sized cortical, subcortical, and leptomeningeal vessels. This deposition
is responsible for the wide spectrum of clinical symptoms and neuroimaging findings. [1,2]
CAA is not associated with the presence of systemic amyloidosis. [3] Majority of cases of CAA
are asymptomatic. However, symptomatic patient may present with sudden neurological
deficit due to transient ischemic attack, progressive cognitive decline, or potentially devastat‐
ing intracranial hemorrhage. [3,4] Computed tomography is the imaging modality of choice
for evaluation of suspected acute intracranial hemorrhage. Magnetic resonance imaging is a
sensitive technique for identifying microhemorrhages, microangiopathy-related ischemic
changes and assessment of disease progression. The early and accurate diagnosis of CAA is
important because of the likely implication it has on future management targeted to reduce
the risk of recurrent hemorrhage. In this chapter our emphasis will be on the complex patho‐
physiology, important clinical and radiological features and the role of imaging in secondary
prevention of CAA related ICH. [1,3,4]
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2. Pathophysiology
CAA is characterized by deposition of β-amyloid protein in media and adventitia of small and
medium-sized cortical, subcortical, and leptomeningeal vessels, with sparing of similar-sized
vessels in the deep white matter. [2] The complex structural changes in the vessel wall related
to β-amyloid deposition include endothelial dysfunction, loss of smooth muscle cells, fibrinoid
necrosis, vessel wall fragmentation (fragile vessel) and microaneurysm formation. All these
factors predispose the patient to repeated episodes of blood vessel leakage and frank hemor‐
rhages in response to sudden increase in blood pressure or minor trauma. [3,4] CAA related
inflammation (termed as cerebral amyloid angitis or cerebral amyloid inflammatory vascul‐
opathy) is typically perivascular and may be associated with frank vasculitis. β-amyloid
deposition causes vessel wall thickening and subsequent luminal narrowing leading to
ischemic changes. [2] The deposition may also impair the perivascular drainage, leading to
dilatation of perivascular spaces (also known as Virchow Robin spaces) within the lobar region
and in deep cerebral white matter. The enlarged perivascular spaces, a potential useful
neuroimaging marker of CAA, can reach several millimeters in diameter and may be visible
on brain imaging. [5,6] Histologically, β-amyloid deposits stained with Congo red show classic
yellow-green birefringence under polarized light. [3]
3. Clinical spectrum
In general, hereditary form of CAA has an earlier onset and more severe clinical manifestations
than sporadic CAA. Symptomatic CAA has variable clinical presentations, which include
sudden neurologic deficit (stroke) related to acute ICH, TIA-like symptoms, cognitive impair‐
ment and dementia. [7]
The most common presentation of CAA is the development of a sudden neurological deficit
secondary to an acute ICH. Specific clinical symptoms and signs depend on both the size and
location of the ICH. CAA can have similar presentation as acute ICH related to other causes:
headache, nausea and vomiting, loss of consciousness, focal neurological deficits and seizures.
[8]
Transient-ischemic attack (TIA) like symptoms also termed as “amyloid spells” is the next most
commonly described presentation. The spells are typically brief (<30mts) and are characterized
by recurrent, stereotyped episodes of ‘positive’ spreading sensory symptoms (paraesthesias).
The spells are related to hemorrhagic components of CAA, for example cortical microbleeds
(CMBs), cortical subarachnoid hemorrhage (cSAH), or cortical superficial siderosis. [4,9]
The prevalence of CAA is significantly higher in demented patients (due to Alzheimer disease)
compared to non-demented patients. CAA-related dementia is slowly progressive, similar to
that seen in patients with Alzheimer disease. [10] CAA is also the direct cause of cognitive
impairment that progresses rapidly over the course of a few weeks. These patients may present
with confusion and disorientation. [3]
Intracerebral Hemorrhage42
4. Neuroimaging correlates of CAA
The Boston criteria (table 1) was first proposed in 1990 in order to standardize the diagnosis
of cerebral amyloid angiopathy. They comprise of combined clinical, imaging and pathological
parameters. [11]
Definite CAA
Full postmortem examination demonstrating:
-Lobar, cortical, or corticosubcortical hemorrhage
-Severe CAA with vasculopathy
-Absence of other diagnostic lesion
Probable CAA with supporting pathology
Clinical data and pathologic tissue demonstrating:
-Lobar, cortical, or corticosubcortical hemorrhage
-Some degree of CAA in specimen
-Absence of other diagnostic lesion
Probable CAA
Clinical data and MRI or CT demonstrating:
-Multiple hemorrhages restricted to lobar, cortical, or corticosubcortical regions
-Age more than 55 years
-Absence of other cause of hemorrhage
Possible CAA
Clinical data and MRI or CT demonstrating:
-Single lobar, cortical, or corticosubcortical hemorrhage
-Age more than 55 years
-Absence of other cause of hemorrhage
CAA: Cerebral amyloid angiopathy
Table 1. Boston criteria for diagnosis of CAA-related hemorrhage
Recognition of the imaging findings of CAA is important for correct diagnosis. The important
imaging correlates of CAA include: (i) large intracranial hemorrhages (ICHs), (ii) cerebral
microbleeds (CMBs), (iii) convexity subarachnoid hemorrhages (cSAH), (iv) cortical superfi‐
cial siderosis, (v) white matter changes (leukoaraiosis), and (vi) prominent VRSs.
The majority of ICHs (>75%) in elderly are spontaneous due to rupture of small arteries affected
by either of the two processes; the hypertensive arteriopathy or CAA. Distribution of ICH
reflects the underlying microangiopathy. Hypertensive arteriopathy is characterized by
lipohyalinosis and fibrinoid necrosis of lenticulostriate perforators located in deep gray nuclei
(i. e. basal ganglia, thalami) and infratentorial location (i. e. pons). In contrast, CAA related
ICH is preferentially lobar (any lobe may be involved); less commonly involves the cerebellum
and rarely the deep nuclei or the brainstem. [12] CAA-related ICH represents 2% of all ICH
and is an important cause of hemorrhage in normotensive elderly patients without trauma.
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Nonenhanced CT helps to exclude the presence or absence of an acute ICH and provides
information regarding the location, size, shape and extension of ICH (Figure 1). MR imaging
is most sensitive for detection of chronic hemorrhages in suspected cases of CAA. After ICH,
hemosiderin remains stored within the macrophages, leads to focal dephasing of the MR
signal, and causes hemosiderin-containing areas to appear dark on T2-weighted spin-echo
sequences. This effect may be further enhanced by the use of imaging techniques with high
sensitivity for differences in magnetic susceptibility, such as the T2*-weighted gradient-echo
(GRE) sequence (Figure 2). The susceptibility-weighted imaging (SWI) has been found to be
more sensitive than conventional GRE techniques for the detection of blood products.
[13,14,15]
Figure 1. Plain axial CT image of a 66-year-old normotensive male reveals a large, right parietal lobe, hyperdense, sub‐
acute hemorrhage (arrow) causing mass effect in form of effacement of adjacent sulci and compression of posterior
part of the body of ipsilateral lateral ventricle. Diffuse periventricular white matter hypodensities (leukoaraiosis) is also
noted.
The hemorrhage is typically lobar and cortical-subcortical in distribution; it generally spares
the deep white matter, basal ganglia and the brainstem. Symptomatic ICH is large (>5mm),
while microhemorrhages (<5mm) are often clinically silent. CAA-related macrohemorrhages
typically exhibit irregular borders (Figure 1) and may be associated with subarachnoid
hemorrhage, subdural hemorrhage, or, less commonly, intraventricular hemorrhage. CMBs
are small, well demarcated; rounded lesions not detected on conventional MRI (Figure 2). The
presence of chronic cortical-subcortical microhemorrhages in association with large ICH
increases the probability of CAA (Figure 3). Multiplicity and recurrence of ICH further favors
CAA. [16,17]
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Figure 3. T2*-weighted gradient-echo MR image of same patient as in figure 1, demonstrates a large right parietal
hematoma in association with multiple chronic cortical-subcortical microhemorrhages (arrows) and periventricular
white matter abnormality (asterisk), thus increasing the probability of CAA.
Figure 2. T2*-weighted gradient-echo MR image of a 62-year-old male patient shows diffuse and small multifocal he‐
mosiderin deposits (chronic microhemorrhages) in corticosubcortical location of both the cerebral hemispheres, seen
as signal void areas (blooming) (arrows).
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Chronic subarachnoid hemorrhage (cSAH) and superficial siderosis are quite characteristic of
CAA. cSAH often results from lobar ICH extending to the cortical surface (Figure 4). Cortical
superficial siderosis describes hemosiderin deposition in the superficial layers of the cerebral
cortex and may follow repeated episodes of bleeding in the subarachnoid space. On T2*-
weighted GRE sequence, cortical superficial siderosis shows a characteristic gyriform pattern
of hypointense signal. [18]
Figure 4. T2*-weighted gradient-echo MR image of same patient as in figure 1, shows two linear areas of signal void
(thin arrows) in the vicinity of large primary lobar hemorrhage (thick arrow) suggest chronic subarachnoid hemor‐
rhage and cortical superficial hemosiderosis.
MRI is also sensitive for identifying CAA-related inflammation and ischemic changes and
assessment of disease progression. [19] Leukoaraiosis, a radiological term which describes
imaging changes in deep cerebral white matter, is a nonspecific finding seen in patients with
CAA and can be due to demyelination, infarction or edema. On imaging, leukoaraiosis appears
as patchy or confluent, CT hypodense or T2/FLAIR (fluid attenuated inversion recovery)
hyperintense white matter abnormality with or without sparing of subcortical U fibers (Figure
5). Leukoaraiosis with sparing of U fibers is secondary to ischemic white matter damage and
is seen in association with long standing dementia; whereas, white matter changes that extend
to involve the U fibers are common in patients with subacute cognitive decline and are
associated with mass effect due to inflammatory edema. [20,21] White matter changes in CAA
increases over time and is an important contributor to overall disease burden. The CAA should
be considered in the broad differential diagnosis of leukoencephalopathy especially if
associated with progressive dementia or cognitive impairment. [13]
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Figure 5. Axial MRI (FLAIR sequence) of the same patient as in figure 2, demonstrates bilateral symmetrical, confluent,
supratentorial periventricular white matter hyperintensity with involvement of posterior subcortical U fibers (thick ar‐
rows). Also note dilated perivascular spaces (Virchow Robin spaces) in deep cerebral white matter (thin arrow).
5. Management prospect and prognosis
Currently, there is no treatment to halt or reverse β-amyloid deposition. Thus, attention is
directed instead to the prevention of adverse outcomes associated with CAA, such as recurrent
hemorrhages or progressive dementia. In this context, MRI may help in selecting patients for
different types of secondary prevention of stroke. MR evidence of higher number of chronic
microbleeds on baseline GRE MR images are predictive of a greater risk of recurrent hemor‐
rhage and future cognitive impairment. A routine use of GRE MRI sequence is suggested to
detect microbleeds in older people to avoid potentially dangerous anticoagulant or antiplatelet
therapy. [22]
The role of neurosurgery in ICH remains to be defined clearly. However, hematoma evacuation
appears relatively safe in patients <75 years of age without intraventricular extension. [23] For
future treatment of CAA, it is important to identify patients early in the course of disease before
ICH or dementia occurs, to allow the use of disease modifying therapies. [24] Tramiprosate
has been found to be a safe treatment option for patients with suspected CAA. Tramiprosate
is an ionic compound that binds with soluble β-amyloid, interferes with the amyloid cascade
and delays or inhibits the progression of CAA. [25]
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6. Summary
• Cerebral amyloid angiopathy (CAA) is an important cause of spontaneous cortical-
subcortical intracranial hemorrhage in the normotensive elderly.
• Leukoencephalopathy in conjunction with acute or chronic ICH in a cortical-subcortical
location increases the diagnostic specificity for CAA.
• Computed tomography is the imaging study of choice for evaluation of suspected acute
cortical hemorrhage.
• MRI is best suited for identification of chronic cortical-subcortical hemorrhages, ischemic
sequelae of the disease and assessment of disease progression.
• The burden of asymptomatic cerebral microhemorrhages detectable by GRE MRI in patients
with CAA is a good predictor of hemorrhage recurrence, and therefore highlights the
importance of secondary prevention in CAA-related PICH.
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